Asset Comparison and Correlation

Considering 30-days investment horizon, BristolMyers Squibb Company is expected to generate 1.36 times more return on investment than Biocon. However, BristolMyers is 1.36 times more volatile than Biocon Limited. It trades about 0.17 of its potential returns per unit of risk. Biocon Limited is currently generating about 0.01 per unit of risk. If you would invest  4,115  in BristolMyers Squibb Company on April 18, 2013 and sell it today you would earn a total of  215.00  from holding BristolMyers Squibb Company or generate 5.22% return on investment over 30 days.